Assoziierte(r) Prof. Dr. Yvonne Teuschl

Bernegger, A.; Mikšová, D.; Posekany, A.; Krebs, S.; Ferrari, J.; Greisenegger, S.; Gattringer, T.; Lang, W.; Kiechl, S.; Sykora, M.; Austrian Stroke Unit Registry Collaborators (2022). Time trends in stroke severity in the years 2005 to 2020: results from the Austrian Stroke Unit Registry. J Neurol., 269(8): 4396-4403

Brainin, M.; Teuschl, Y.; Martin S. (2022). Polypill: Benefits Seen for Stroke and Other Outcomes. Stroke, 53(8): 2695-2701

GBD 2019 Stroke Collaborators (2021). Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol, 20(10): 795-820

Quinn, T.J.; Richard, E.; Teuschl, Y.; Gattringer, T.; Hafdi, M.; O'Brien, J.T.; Merriman, N.; Gillebert, C.; Huyglier, H.; Verdelho, A.; Schmidt, R.; Ghaziani, E.; Forchammer, H.; Pendlebury, S.T.; Bruffaerts, R.; Mijajlovic, M.; Drozdowska, B.A.; Ball, E.; Markus, H.S. (2021). European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment. Eur Stroke J, 6: I-XXXVIII

Quinn, T.J.; Richard, E.; Teuschl, Y.; Gattringer, T.; Hafdi, M.; O'Brien, J.T.; Merriman, N.; Gillebert, C.; Huyglier, H.; Verdelho, A.; Schmidt, R.; Ghaziani, E.; Forchammer, H.; Pendlebury, S.T.; Bruffaerts, R.; Mijajlovic, M.; Drozdowska, B.A.; Ball, E.; Markus, H.S. (2021). European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment. Eur J Neurol, 28(12): 3883-3920.

Teuschl, Y.; Bancher, C.; Brainin, M.; Dachenhausen, A.; Matz, K.; Pinter MM. (2021). COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study. J Neural Transm, Oct 23: 1–5

Gabriel, R.;, Boukichou Abdelkader, N. et al (e-PREDICE Consortium) (2020). Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data. PLoS ONE, 15(4): e0231196

Matz, K.; Tuomilehto, J.; Teuschl, Y.; Dachenhausen, A.; Brainin, M. (2020). Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke. Cardiovascular Diabetology, 19(1): 204

Matz, K.; Tuomilehto, J.; Teuschl, Y.; Dachenhausen, A.; Brainin, M. (2020). Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke. Cardiovascular Diabetology, 19: https://doi.org/10.1186/s12933-020-01182-6

Teuschl, Y.; Matz, K.; Dachenhausen, A.; Brainin, M. (2020). Impaired glucose metabolism and cognitive performance after mild stroke.

Brainin, M.; Feigin, V.; Bath, PM.; Collantes, E.; Martins, S.; Pandian, J.; Sacco, R.; Teuschl Y. (2019). Multi-level community interventions for primary stroke prevention: A conceptual approach by the World Stroke Organization. Int J Stroke, 1747493019873706: 10.1177/1747493019873706

Brainin, M.; Teuschl, Y; Matz, K. (2019). Common risk factors and prevention. In: Textbook of Stroke Medicine, third edition: 130, Cambridge University Press, UK

Tuomilehto, J.; Teuschl, Y. (2019). Basic epidemiology of stroke and risk assessment. In: Textbook of Stroke Medicine, third edition: 109, Cambridge University Press, UK

ASPIS Study Group (2018). Multidomain intervention for the prevention of cognitive decline after stroke - a pooled patient-level data analysis. Eur J Neurol., 25: 1182-1188

Brainin, M.; Feigin, V.; Martins, S.; Matz, K.; Roy, J.; Sandercock, P.; Teuschl, Y.; Tuomilehto, J.; Wiseman, A. (2018). Cut stroke in half: Polypill for primary prevention in stroke. Int J Stroke, 25: 633-647

Brainin, M; Teuschl, Y. (2018). Poststroke Neurocognitive Disorders Are Mostly Defined by Strategic Lesions. Stroke, 49/11: 2563-2564

Teuschl, Y.; Trapl, M:, Ratajczak, P.; Matz, K.; Dachenhausen, A.; Brainin, M. (2018). Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. PLoS One, :e0192142: 10.1007/s00415-017-8720-8.

Mijajlovic, M.D.; Pavlovic, A.; Brainin, M.; Heiss, W.D.; Quinn, T.J.; Ihle-Hansen, H.B.; Hermann, D.M.; Assayag, E.B.; Richard, E.; Thiel, A.; Kliper, E.; Shin, Y.I.; Kim, Y.H.; Choi, S.; Jung, S.; Lee, Y.B.; Sinanovic, O.; Levine, D.A.; Schlesinger, I.; Mead, G.; Miloševic, V.; Leys, D.; Hagberg, G.; Ursin, M.H.; Teuschl, Y.; Prokopenko, S.; Mozheyko, E.; Bezdenezhnykh, A.; Matz, K.; et al. (2017). Post-stroke Dementia - a comprehensive review. BMC Medicine, 15(1):11: doi: 10.1186/s12916-017-0779-7

Teuschl, Y.; Matz, K.; Firlinger, B.; Dachenhausen, A.; Tuomilehto, J.; Brainin, M.; ASPIS Study Group. (2017). Preventive effects of multiple domain interventions on lifestyle and risk factor changes in stroke survivors: Evidence from a two-year randomized trial. International Journal of Stroke, 12(9): 976-984

Trapl, M.; Teuschl, Y.; Matz, K.; Dachenhausen, A.; Brainin, M. (2017). Overestimating the risk of aspiration in acute stroke. European Journal of Neurology, 24(6): doi:10.1111/ene.13298